Buprenorphine / Naloxone Sublingual Tablets

Buprenorphine / Naloxone Sublingual Tablets
Product Description

Buprenorphine/Naloxone Sublingual Tablets are indicated for the treatment of opioid dependence as part of a comprehensive medical, social, and psychological support program. The combination of buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, is designed to reduce withdrawal symptoms and cravings while discouraging misuse. Administered sublingually, the tablets provide effective and controlled absorption, supporting stabilization and maintenance therapy in patients with opioid addiction. Available in two strengths (2 mg / 0.5 mg and 8 mg / 2 mg), the product allows flexible dosing tailored to patient needs. It is suitable for adult patients and adolescents over 15 years of age under medical supervision.

Read more Show less

Ethypharm

  • Country/Region:
    France
  • Founded:
    1977
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    1000 - 4999
Company types
Contract Service
Distributor/Import Export
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (innovator finished products)
View company profile
Categories
more categories Show less
Specifications
  • Details
  • Active substances: Buprenorphine (as hydrochloride) and naloxone (as hydrochloride dihydrate)
  • Pharmaceutical form: Sublingual tablets
  • Strengths: 2 mg / 0.5 mg and 8 mg / 2 mg
  • Route of administration: Sublingual (placed under the tongue until dissolved)
  • Indication:
    • Substitution treatment for opioid dependence
    • Used in combination with medical, psychological, and social support
  • Pack sizes: 7 tablets and 28 tablets
  • Shelf life: 2 years
  • Storage: Do not store above 30°C
  • Selling Points
    International Approvals/Standards; Packaging; Quality Service;
  • Effective treatment for opioid dependence
  • Dual mechanism combining buprenorphine and naloxone
  • Reduces cravings and withdrawal symptoms
  • Designed to deter misuse and abuse
  • Flexible dosing options with two strengths
  • Suitable for long-term maintenance therapy
  • Part of a comprehensive addiction treatment approach
  • Model
    2 mg / 0.5 mg and 8 mg / 2 mg
  • Supplied from
    France
  • Measured In
    milligram
    • More specifications Fewer specifications
    Sales Markets
    Show more Show less

    Ethypharm

    • Country/Region:
      France
    • Founded:
      1977
    • On CPHI since:
      2015
    • Certificates:
      4
    • Employees:
      1000 - 4999
    Company types
    Contract Service
    Distributor/Import Export
    Manufacturer/Innovator
    Pharmaceutical company
    Primary activities
    Contract Manufacturer
    Pharmaceutical Company (innovator finished products)
    View company profile

    More Products from Ethypharm (11)

    • Ampoules

      Product Ampoules

      Ethypharm has 2 sites for sterile ampoules manufacturing
    • Pellets in Capsules

      Product Pellets in Capsules

      Ethypharm has a strong expertise in manufacturing capsules containing modified release pellets
    • Adrenaline (Epinephrine) Solution for Injection

      Product Adrenaline (Epinephrine) Solution for Injection

      Adrenaline Solution for Injection is a fast-acting emergency medicine used for the treatment of life-threatening conditions such as anaphylaxis and cardiac arrest. It contains epinephrine, a potent sympathomimetic agent that stimulates alpha and beta-adrenergic receptors, resulting in rapid vasoconstrictio...
    • Argatroban Solution for Infusion

      Product Argatroban Solution for Infusion

      Argatroban is a direct thrombin inhibitor used for anticoagulation in patients with heparin-induced thrombocytopenia type II (HIT II). It is administered by continuous IV infusion and offers rapid, predictable anticoagulant effects. Available as a ready-to-use solution or a concentrate for dilution, it pro...
    • Buprenorphine Oral Lyophilisate

      Product Buprenorphine Oral Lyophilisate

      Buprenorphine Oral Lyophilisate is a rapidly dispersing formulation designed for the treatment of opioid dependence as part of a comprehensive care program including medical, social, and psychological support. The product contains buprenorphine, a partial opioid agonist that helps reduce withdrawal symptom...
    • CDMO Capabilities

      Product CDMO Capabilities

      A wide range of dosage forms & packagings

      1. INJECTABLES 
      2. DRY FORMS 
      3. ORAL SOLUTIONS
    • Clobazam Oral Suspension

      Product Clobazam Oral Suspension

      Clobazam Oral Suspension is a benzodiazepine indicated as adjunctive therapy in epilepsy when standard treatments are insufficient. It offers flexible dosing and is suitable for patients who require a liquid formulation, including paediatric populations. Available in two strengths and multiple bottle sizes...
    • Esomeprazole Gastro-resistant Capsules

      Product Esomeprazole Gastro-resistant Capsules

      Ventra® is an esomeprazole-based gastro-resistant capsule designed for effective acid management and long-lasting gastric protection. Available in 20 mg and 40 mg strengths, it utilizes advanced microgranule technology to ensure controlled and sustained drug release, improving absorption and reducing varia...
    • Fenofibrate 145 mg Tablets

      Product Fenofibrate 145 mg Tablets

      Fenofibrate Ethypharm 145 mg is a lipid-lowering medication designed to support the management of dyslipidaemia and reduce cardiovascular risk. It is indicated as an adjunct to diet and lifestyle modifications for the treatment of severe hypertriglyceridaemia and mixed hyperlipidaemia. The formulation util...
    • Levobupivacaine Solution for Injection/Infusion

      Product Levobupivacaine Solution for Injection/Infusion

      Levobupivacaine is a long-acting local anaesthetic used for regional anaesthesia and pain management. It provides effective anaesthesia and analgesia across a wide range of clinical settings, including surgery and labour. With a similar efficacy profile to bupivacaine but lower cardiovascular and CNS toxic...
    • Morphine Sulphate Oral Solution

      Product Morphine Sulphate Oral Solution

      Morphine Sulphate Oral Solution 10 mg/5 mL is a clear liquid formulation indicated for the relief of severe pain. Containing morphine sulfate pentahydrate, it is designed for oral administration and provides reliable and flexible dosing for both adult and paediatric patients when prescribed appropriately. ...